An innovative antibiotic combining efficacy, safety and ease of use.
Veraflox® is approved for the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida, Streptococcus canis, Streptococcus aureus, Staphylococcus felis and Staphylococcus pseudintermedius.
Veraflox® is bactericidal, with activity against Gram-negative, Gram-positive and anaerobic bacteria
The unique molecular structure of pradofloxacin was specifically engineered with high-affinity dual targeting to offer a broad-spectrum of bactericidal activity compared to previous generation fluoroquinolones.
Flavored, well-accepted, once-daily oral suspension with a user-friendly, low-mess dispenser.